Zura Bio (ZURA) Operating Expenses (2022 - 2026)
Zura Bio (ZURA) posted quarterly Operating Expenses of $25.5 million for Q1 2026, up 32.43% year-over-year from $19.3 million in Q1 2025, and up 38.5% quarter-over-quarter from $18.4 million in Q4 2025.
Zura Bio (ZURA) Operating Expenses (2022 - 2026) Analysis & Trends
Zura Bio's Operating Expenses history runs 5 years deep, the most recent figure standing at $25.5 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 32.43% year-over-year to $25.5 million; the TTM figure through Mar 2026 stood at $81.5 million (up 23.35% YoY), while the FY2025 annual figure was $75.2 million, up 36.34% from the prior year.
- Operating Expenses for Q1 2026 stood at $25.5 million, up from $18.4 million in the prior quarter.
- The five-year high for Operating Expenses was $33.9 million in Q2 2023, with the low at $927000.0 in Q2 2022.
- The 5-year median for Operating Expenses is $15.7 million (2024), against an average of $14.5 million.
- The sharpest annual moves came in 2023 and 2024: Operating Expenses jumped 3557.5% in 2023, then slumped 65.32% in 2024.
- Zura Bio's Operating Expenses stood at $17.3 million in 2022, then slumped by 37.59% to $10.8 million in 2023, then surged by 45.3% to $15.7 million in 2024, then advanced by 17.03% to $18.4 million in 2025, then surged by 38.5% to $25.5 million in 2026.
- Business Quant data shows ZURA's Operating Expenses at $25.5 million in Q1 2026, $18.4 million in Q4 2025, and $19.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Zura Bio | 706.30 Mn | 706.30 Mn | - | 29.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.32 Mn |
| Mar 31, 2026 | 25.50 Mn |
| Dec 31, 2025 | 18.41 Mn |
| Sep 30, 2025 | 19.52 Mn |
| Jun 30, 2025 | 18.06 Mn |
| Mar 31, 2025 | 19.25 Mn |
| Dec 31, 2024 | 15.73 Mn |
| Sep 30, 2024 | 19.32 Mn |
| Jun 30, 2024 | 11.76 Mn |
| Mar 31, 2024 | 8.38 Mn |
| Dec 31, 2023 | 10.83 Mn |
| Sep 30, 2023 | 10.19 Mn |
| Jun 30, 2023 | 33.91 Mn |
| Mar 31, 2023 | 7.72 Mn |
| Dec 31, 2022 | 17.35 Mn |
| Sep 30, 2022 | 1.07 Mn |
| Jun 30, 2022 | 927,000.00 |
| Mar 31, 2022 | 7.82 Mn |